BIONDVAX PHARMACEUTICALS-ADR (BVXV) Stock Income Statement
NASDAQ:BVXV - Nasdaq - US09073Q2049 - ADR - Currency: USD
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 9.52M | -7.33M | 78.35M | 77.07M | 23.66M | |||
| Research and Development | 2.32M | 49.58M | 67.35M | 71.72M | 18.47M | |||
| Selling, General, and Administrative Expenses | 6.55M | 16.14M | 9.35M | 5.09M | 4.75M | |||
| Operating Income | -9.52M | 7.33M | -78.35M | -77.07M | -23.66M | |||
| Interest Income/Expense | -1.41M | -11.79M | -30.84M | -10.66M | -10.90M | |||
| Income Before Taxes | -10.92M | -4.46M | -109.19M | -87.73M | -34.55M | |||
| Net Income | -10.92M | -4.46M | -109.19M | -87.73M | -34.55M | |||
| EBITDA | -8.88M | 9.77M | -76.70M | -76.81M | -23.22M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -6.86 | -3.55 | -117.04 | -120.59 | -60.30 | |||
| Non GAAP EPS | N/A | -1.26 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD